3401 - 3410 of 5832 Results
Title
Year
- Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate2020OPENTitle: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 138Issue #:Start Page: 104789End Page: 104789Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104789Citation Count: 27
-
OPENTitle: Validation of a Parkinson Disease Predictive Model in a Population-Based StudyJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/2857608Best OA location URL: https://doi.org/10.1155/2020/2857608Citation Count: 9
-
OPENTitle: Well Water and Parkinson’s Disease in Medicare Beneficiaries: A Nationwide Case-Control StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 693End Page: 705Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191793Best OA location URL: https://europepmc.org/articles/pmc7342021?pdf=renderCitation Count: 11
- A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra2020OPENTitle: A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigraJournal Name: Aging CellPublisher: WileyVol: 19Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13115Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13115Citation Count: 56
- Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study2020OPENTitle: Disease progression and prognostic factors in multiple system atrophy: A prospective cohort studyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104813End Page: 104813Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104813Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104813Citation Count: 65
-
OPENTitle: Longitudinal change in autonomic symptoms predicts activities of daily living and depression in Parkinson’s diseaseJournal Name: Clinical Autonomic ResearchPublisher: Springer Science and Business Media LLCVol: 30Issue #: 3Start Page: 223End Page: 230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10286-020-00672-7Best OA location URL: https://cdr.lib.unc.edu/downloads/v118rp109Citation Count: 18
-
OPENTitle: Tossing and Turning in Bed: Nocturnal Movements in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 959End Page: 968Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28006Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/220357/220357.pdfCitation Count: 44
-
OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 31
-
OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 56
- Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment2020OPENTitle: Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatmentJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00362-yBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00362-yCitation Count: 67